期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
二甲双胍联合中医补肾活血化痰法治疗多囊卵巢综合征的疗效观察 被引量:4
1
作者 宿殊品 刘艳伟 +1 位作者 彭敏 高柏钊 《中国实用医药》 2012年第17期159-160,共2页
目的对应用二甲双胍对患有多卵巢综合征的患者进行治疗时,联合中医补肾活血化痰法治疗,并对体会进行总结,为今后临床对该类患者进行更好的治疗提供可靠的依据和方法。方法随机抽取在2007年3月至2011年3月这四年时间里,在我院就诊的患有... 目的对应用二甲双胍对患有多卵巢综合征的患者进行治疗时,联合中医补肾活血化痰法治疗,并对体会进行总结,为今后临床对该类患者进行更好的治疗提供可靠的依据和方法。方法随机抽取在2007年3月至2011年3月这四年时间里,在我院就诊的患有多卵巢综合征的确诊患者病例58例,将其随机分为A、B两组,平均每组29例。A组患者采用二甲双胍进行治疗;B组患者在A组基础上联合中医补肾活血化痰法治疗。对两组患者的疗效进行比较分析,对体会进行总结。结果研究结果显示,二甲双胍对多卵巢综合征能够起到很好的治疗效果,但B组患者的治疗效果和患者的治疗效果更为理想,与A组比较差异有统计学意义(P<0.05);B组患者治疗后和恢复期间的不良反应和并发症的发生率明显低于A组患者,差异有统计学意义(P<0.05)。结论采用二甲双胍对患有多卵巢综合征的患者进行治疗,期临床治疗效果令人满意,联合中医补肾活血化痰法辅助治疗能够使临床治疗效果大大提高,还可以使治疗期间的不良反应和并发症的发生率显著下降。 展开更多
关键词 二甲双胍 补肾活血化痰法 多卵巢综合征
在线阅读 下载PDF
Association between Two Polymorphisms of Follicle Stimulating Hormone Receptor Gene and Susceptibility to Polycystic Ovary Syndrome: a Meta-analysis 被引量:3
2
作者 Lei Qiu Jing Liu Qi-ming Hei 《Chinese Medical Sciences Journal》 CAS CSCD 2015年第1期44-50,共7页
Objective To investigate the association between two polymorphisms of follicle stimulating hormone receptor (FSHR) gene and polycystic ovary syndrome (PCOS) susceptibility. Methods Case-control studies on relatio... Objective To investigate the association between two polymorphisms of follicle stimulating hormone receptor (FSHR) gene and polycystic ovary syndrome (PCOS) susceptibility. Methods Case-control studies on relationship of Thr307Ala and Asn680Ser polymorphisms in FSHR gene and PCOS susceptibility were searched from PubMed, ISI web of knowledge, EBSCO, and China National Knowledge Infrastructure (CNKI) databases up to March 21, 2013. The pooled odds ratio (OR) and 95% confidence interval (CO were calculated using fixed- or random-effect model based on heterogeneity test in 5 genotype models analyses. Results A total of 11 studies were included in the Meta-analysis. The random-effect analysis showed Asn680Ser was significantly associated with the reduced susceptibility to PCOS with dominant model (Asn/Asn+Asn/Ser vs. Ser/Ser, OR=0.83, 95% CI: 0.69-1.00), recessive model (Asn/Asn vs. Asn/Ser+ Ser/Ser, OR=0.84, 95% CI: 0.72-0.98), homozygote comparison (Ash/Ash vs. Ser/Ser, 0R=0.79, 95% CI: 0.63-0.98), and the allele contrast (Asn vs. Ser, OR=0.87, 95% CI: 0.79-0.97) respectively(P=0.02, I2=56.0%), being protective factors for PCOS. However, no significant associations were found between Thr307Ala and PCOS. Conclusion There might be a significant association between Asn680Ser polymorphism and PCOS. 展开更多
关键词 follicle stimulating hormone receptor polycystic ovary syndrome META-ANALYSIS single-nucleotide polymorphism
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部